Chronic Myeloid Leukemia

CHRONIC MYELOID LEUKEMIA ADVISOR

HEADLINES
TREATMENT REGIMENS
DRUG INFORMATION

FEATURED CONTENT

British Society for Haematology Guideline Update for the Diagnosis and Management of Chronic Myeloid Leukemia

The British Society for Haematology has published updated guidelines for the diagnosis and management of chronic myeloid leukemia in adults and children.
Reliability of Laboratory-Developed Tests Called Into Question

A recent HHS announcement spurred concern that FDA oversight of LDTs was eroding, threatening patient safety — but the reality is less dire.
How the Coronavirus Pandemic May Affect Cancer Clinical Trials

Risks of moving clinical trials online include missing key information about the patient experience — and higher dropout rates could also impair the overall quality of trials.
The Twitter Effect on How Oncologists Conduct and Share Research

The social media platform can be useful as an education tool for oncologists to stay up to date on new research in oncology — but physicians still need to be mindful of the information sources.
How Patients Lose Their Own Voices: Disparities in Patient-Reported Outcome Capture in Clinical Trials

It remains important to interrogate how structural discrimination influences the collection of patient-reported outcomes.

VIDEO SERIES

Ponatinib for CML

Progress in the CML Landscape

Treatment Options

Sequencing Treatment

Choosing the Appropriate TKI

Monitoring Treatment Response

Monitoring Adherence

Switching Therapies

Discontinuing Treatment

Known Factors in TKI Resistance

Managing Adverse Events

Allogeneic Stem Cell Transplant

CML: On the Horizon

The Future of CML Treatment

CHRONIC MYELOID LEUKEMIA NEWS

Managing adverse effects after starting a TKI can be challenging, and health care practitioners ofte

First-line Therapy Response vs Switching Treatments in Chronic Myeloid Leukemia

October 19, 2020

Image of chronic lymphocytic leukemia cells

Patients With CML Continue to Be Prescribed Costly Second-Gen TKIs

October 9, 2020

Managing adverse effects after starting a TKI can be challenging, and health care practitioners ofte

Study Provides Support for TKI Discontinuation in Some Patients With CML

June 12, 2020

Early Monitoring of Chronic Myeloid Leukemia Might Dictate TKI Switch

April 20, 2020

This study led to the first clinical trial in humans to test trabectedin for CLL.

Asciminib Shows Clinical Activity for Pretreated CML in Phase 1 Trial

January 13, 2020

Next post in Chronic Myeloid Leukemia

Managing adverse effects after starting a TKI can be challenging, and health care practitioners ofte

First-line Therapy Response vs Switching Treatments in Chronic Myeloid Leukemia